Novel strategy discovered for FLT3-ITD-positive acute myeloid leukemia

Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
Credit: HU Chen

A new type of targeting chaperon protein HSP70 inhibitor QL47 was recently discovered by a team led by Prof. LIU Qingsong from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences to treat FLT3-ITD-positive acute myeloid leukemia (AML). Their findings have been published on Signal Transduction and Targeted Therapy.

“What we are seeking is a new therapeutic strategy which imperative for FLT3-ITD-positive AML,” said HU Chen, lead author of the study.

Approximately, 25% of AMLs carry FLT3-ITD (internal tandem duplication) oncogenic mutations, and FLT3 kinase inhibitors have already achieved great success in the clinic for FLT3-ITD-positive AML. However, after prolonged treatment, drug-acquired resistance is observed in patients treated with FLT3 kinase inhibitor.

In this research, the researchers found that compound QL47 had potent anti-proliferative activity against FLT3-ITD positive AML cell lines and induces FLT3-ITD protein degradation.

Further study proved that QL47 irreversibly bound to the heat shock protein HSP70 and inhibited its refolding activity, which in turn led to the degradation of FLT3-ITD and inhibited proliferation of the FLT3-ITD positive AML cells.

“It is inducible HSP70 instead of constitutive expressed HSC70 that is important for FLT3 protein stabilization and FLT3-ITD-positive cell viability,” said Dr. HU.

The evaluation of QL47 in primary patient cells and in vivo tumor models showed that QL47 induced the degradation of FLT3-ITD protein and cell apoptosis in primary patient cells. In mice bone marrow engraftment model, QL47 significantly extends the animal survivals.

“Targeting the chaperone protein HSP70 could potentially provide a novel strategy for FLT3-ITD-positive AML treatment,” said HU.

Journal: Signal Transduction and Targeted Therapy
DOI: 10.1038/s41392-021-00672-7
Method of Research: Experimental study
Subject of Research: Not applicable
Article Title: Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia
Article Publication Date: 15-Sep-2021

Media Contact

Weiwei Zhao
Hefei Institutes of Physical Science, Chinese Academy of Sciences
annyzhao@ipp.ac.cn
Office: 86-551-655-91206

Media Contact

Weiwei Zhao
Hefei Institutes of Physical Science, Chinese Academy of Sciences

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Under arrest: Using nanofibers to stop brain tumor cells from spreading

Researchers from Japan develop a platform based on nanofibers to trap brain cancer cells as a therapeutic strategy. Our body heals its injuries by essentially replacing damaged cells with new…

New photonic chip for isolating light may be key to miniaturizing quantum devices

Light offers an irreplaceable way to interact with our universe. It can travel across galactic distances and collide with our atmosphere, creating a shower of particles that tell a story…

A traffic light for light-on-a-chip

Integrated photonics allow us to build compact, portable, low-power chip-scale optical systems used in commercial products, revolutionizing today’s optical datacenters and communications. But integrating on-chip optical gain elements to build…

Partners & Sponsors